Home › Funds › Divisadero Street Capital Management, LP › INDV

Divisadero Street Capital Management, LP position in INDV

INDIVIOR PHARMACEUTICALS INC · Health Care

Divisadero Street Capital Management, LP reported holding 1,470,476 shares of INDV (INDIVIOR PHARMACEUTICALS INC) in its Q3 2026 13F filing — a position valued at US$52.7M, representing 1.06% of its reported portfolio and ranking #28 among its reported holdings. Divisadero Street Capital Management, LP has disclosed INDV holdings in 6 of the last 6 reported quarters, going back to Q2 2025.

Latest position (Q3 2026)1.47M sh
Reported value held$52.72M
Portfolio Weight1.06%
First reportedQ2 2025
Last changeAdd
Updated2026-11-17

Last updated: 2026-11-17 · Source: SEC EDGAR Form 13F-HR

How Divisadero Street Capital Management, LP's INDV position evolved

Divisadero Street Capital Management, LP first disclosed a stake in INDV in Q2 2025 at 136,000 shares (US$2.0M). The position peaked in Q4 2025 at 2,784,786 shares, worth US$99.9M. Across 6 filings, Divisadero Street Capital Management, LP increased the stake 3 time(s), trimmed it 2 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 1,470,476 shares valued at US$52.7M — an increase of 868,613 shares quarter over quarter.. Notable position changes include a 2373% increase in Q3 2025 (shares rose 49% over the following quarter), a 81% trim in Q1 2026 (shares rose 35% over the following quarter), a 144% increase in Q3 2026 (shares rose 1% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q2 2025 136.00K $2.00M New
Q3 2025 3.36M $81.07M Add
Q4 2025 2.78M $99.92M Reduce
Q1 2026 521.08K $15.88M Reduce
Q2 2026 601.86K $24.69M Add
Q3 2026 1.47M $52.72M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About INDV and 13F data

INDV (INDIVIOR PHARMACEUTICALS INC) is a Health Care company. 46 other funds we track also report a position in INDV — the largest reported positions include OAKTREE CAPITAL MANAGEMENT LP (US$251.4M), MILLENNIUM MANAGEMENT LLC (US$225.2M), Madison Avenue Partners, LP (US$173.9M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding INDV

All INDV fund holders →

FAQ

How long has Divisadero Street Capital Management, LP held INDV?

Divisadero Street Capital Management, LP has disclosed INDV holdings in 6 of the last 6 reported quarters, going back to Q2 2025.

What is Divisadero Street Capital Management, LP's current position in INDV?

As of Q3 2026, Divisadero Street Capital Management, LP holds 1.47M shares of INDV (INDIVIOR PHARMACEUTICALS INC), valued at $52.72M, representing 1.06% of its reported portfolio and ranking #28.

Has Divisadero Street Capital Management, LP been buying or selling INDV?

In the latest 13F filing (Q3 2026), Divisadero Street Capital Management, LP increased its position in INDV. The position peaked in Q4 2025 at 2.78M shares.

Which other funds hold INDV?

Other major institutional holders of INDV include OAKTREE CAPITAL MANAGEMENT LP, MILLENNIUM MANAGEMENT LLC, Madison Avenue Partners, LP, among 46 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.